Aline Pfefferle

863 total citations
17 papers, 500 citations indexed

About

Aline Pfefferle is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Aline Pfefferle has authored 17 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Aline Pfefferle's work include Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (11 papers) and CAR-T cell therapy research (7 papers). Aline Pfefferle is often cited by papers focused on Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (11 papers) and CAR-T cell therapy research (7 papers). Aline Pfefferle collaborates with scholars based in Sweden, Norway and United States. Aline Pfefferle's co-authors include Nicholas D. Huntington, Karl‐Johan Malmberg, Ebba Sohlberg, Bénédikt Jacobs, Jodie P. Goodridge, Eva Hellström‐Lindberg, Vincent Yi Sheng Oei, Vivien Béziat, Lisa L. Liu and Ryan J. Mailloux and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and Blood.

In The Last Decade

Aline Pfefferle

15 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aline Pfefferle Sweden	12	367	257	106	62	26	17	500
Anna Turletti Italy	6	148 0.4×	231 0.9×	72 0.7×	29 0.5×	15 0.6×	13	354
Yuhua Qiu China	10	192 0.5×	134 0.5×	98 0.9×	48 0.8×	10 0.4×	27	341
Lisa Bruns Germany	6	167 0.5×	63 0.2×	64 0.6×	34 0.5×	26 1.0×	8	300
Alana M. Neale Australia	7	266 0.7×	148 0.6×	165 1.6×	10 0.2×	82 3.2×	8	386
S. Rhiannon Jenkinson United Kingdom	8	419 1.1×	170 0.7×	184 1.7×	16 0.3×	29 1.1×	10	581
Linda M. Hartkamp Netherlands	6	207 0.6×	134 0.5×	99 0.9×	32 0.5×	22 0.8×	8	350
Damiano Rami United Kingdom	5	198 0.5×	139 0.5×	148 1.4×	25 0.4×	7 0.3×	6	384
Haejung Won United States	10	311 0.8×	293 1.1×	213 2.0×	36 0.6×	26 1.0×	12	563
Yoshihisa Arita Japan	6	237 0.6×	346 1.3×	124 1.2×	16 0.3×	10 0.4×	7	461
Adrian Tempescul France	12	139 0.4×	110 0.4×	125 1.2×	89 1.4×	10 0.4×	46	408

Countries citing papers authored by Aline Pfefferle

Since Specialization

Citations

This map shows the geographic impact of Aline Pfefferle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline Pfefferle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline Pfefferle more than expected).

Fields of papers citing papers by Aline Pfefferle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aline Pfefferle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline Pfefferle. The network helps show where Aline Pfefferle may publish in the future.

Co-authorship network of co-authors of Aline Pfefferle

This figure shows the co-authorship network connecting the top 25 collaborators of Aline Pfefferle. A scholar is included among the top collaborators of Aline Pfefferle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aline Pfefferle. Aline Pfefferle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Pfefferle, Aline & Karl‐Johan Malmberg. (2025). Rewiring natural killer cells for next-generation cancer therapies. Cancer Cell. 43(11). 1980–1982.

Pfefferle, Aline, Els Verhoeyen, Kimberly S. Schluns, et al.. (2024). Optimisation of a primary human CAR‐NK cell manufacturing pipeline. Clinical & Translational Immunology. 13(5). e1507–e1507. 11 indexed citations

Pfefferle, Aline, et al.. (2024). Egr2 to the rescue: nanoparticles revitalize natural killer cells in the fight against cancer. The EMBO Journal. 43(13). 2527–2529.

Pfefferle, Aline, Jodie P. Goodridge, Ebba Sohlberg, et al.. (2024). Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping. Nature Immunology. 25(8). 1445–1459. 28 indexed citations

Sauer, Julia, Nadine Binder, Aline Pfefferle, et al.. (2022). Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany – a cross-sectional survey conducted as part of a randomised comparative effectiveness trial. BMC Geriatrics. 22(1). 564–564. 5 indexed citations

Foroutan, Momeneh, Ramyar Molania, Aline Pfefferle, et al.. (2021). The Ratio of Exhausted to Resident Infiltrating Lymphocytes Is Prognostic for Colorectal Cancer Patient Outcome. Cancer Immunology Research. 9(10). 1125–1140. 21 indexed citations

Sohlberg, Ebba, Aline Pfefferle, Eivind Heggernes Ask, et al.. (2021). Perturbed NK-cell homeostasis associated with disease severity in chronic neutropenia. Blood. 139(5). 704–716. 10 indexed citations

Pfefferle, Aline, Bénédikt Jacobs, Alvaro Haroun-Izquierdo, et al.. (2020). Deciphering Natural Killer Cell Homeostasis. Frontiers in Immunology. 11. 812–812. 43 indexed citations

Pfefferle, Aline & Nicholas D. Huntington. (2020). You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy. Cancers. 12(3). 706–706. 89 indexed citations

10.

Pfefferle, Aline, Bénédikt Jacobs, Eivind Heggernes Ask, et al.. (2019). Intra-lineage Plasticity and Functional Reprogramming Maintain Natural Killer Cell Repertoire Diversity. Cell Reports. 29(8). 2284–2294.e4. 37 indexed citations

11.

Jacobs, Bénédikt, Aline Pfefferle, Dennis Clement, et al.. (2018). Induction of the BIM Short Splice Variant Sensitizes Proliferating NK Cells to IL-15 Withdrawal. The Journal of Immunology. 202(3). 736–746. 8 indexed citations

12.

Liu, Lisa L., Vivien Béziat, Vincent Yi Sheng Oei, et al.. (2017). Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells. Cancer Immunology Research. 5(8). 654–665. 61 indexed citations

13.

Liu, Lisa L., Aline Pfefferle, Vincent Yi Sheng Oei, et al.. (2015). Harnessing adaptive natural killer cells in cancer immunotherapy. Molecular Oncology. 9(10). 1904–1917. 30 indexed citations

14.

Sohlberg, Ebba, Aline Pfefferle, Sandra Andersson, et al.. (2015). Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome. Oncotarget. 6(33). 34178–34190. 31 indexed citations

15.

Wennerberg, Erik, Aline Pfefferle, Lars Ekblad, et al.. (2014). Human Anaplastic Thyroid Carcinoma Cells Are Sensitive to NK Cell–Mediated Lysis via ULBP2/5/6 and Chemoattract NK Cells. Clinical Cancer Research. 20(22). 5733–5744. 50 indexed citations

16.

Brenner, Dirk, Anne Brüstle, Gloria Lin, et al.. (2014). Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells. Proceedings of the National Academy of Sciences. 111(3). 1060–1065. 40 indexed citations

17.

Pfefferle, Aline, et al.. (2012). Glutathionylation of UCP2 sensitizes drug resistant leukemia cells to chemotherapeutics. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(1). 80–89. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact